(RHM) Rheinmetall - Overview
Exchange: XETRA •
Country: Germany •
Currency: EUR •
Type: Common Stock •
ISIN: DE0007030009
Stock: Vehicles, Weapons, Ammunition, Electronics, Power
Total Rating 65
Risk 84
Buy Signal -0.66
| Risk 5d forecast | |
|---|---|
| Volatility | 42.0% |
| Relative Tail Risk | -5.00% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.74 |
| Alpha | 38.11 |
| Character TTM | |
|---|---|
| Beta | 0.118 |
| Beta Downside | -0.477 |
| Drawdowns 3y | |
|---|---|
| Max DD | 27.43% |
| CAGR/Max DD | 3.12 |
EPS (Earnings per Share)
Revenue
Risks
Fundamental:
P/E ratio: 86.4822
Description: RHM Rheinmetall March 05, 2026
Rheinmetall AG is a German technology company specializing in mobility and security. The company operates globally, with a significant presence in Europe, North and South America, and Asia.
Its business model is diversified across five segments: Vehicle Systems, Weapon and Ammunition, Electronic Solutions, Power Systems, and Others. The Vehicle Systems segment focuses on military vehicles, including armored and logistics vehicles. The Weapon and Ammunition segment provides defense solutions such as weapons, ammunition, and protection systems. The Electronic Solutions segment offers integrated defense electronics, including sensors, air defense, and simulation systems.
The Power Systems segment, in contrast to the other segments, serves the automotive and energy industries with products for air and thermal management, e-mobility, and hydrogen technology. This segment also engages in aftermarket activities. The Aerospace & Defense industry is characterized by long product lifecycles and significant R&D investment.
For a deeper dive into Rheinmetalls financials and market position, consider exploring ValueRays detailed analysis.
Headlines to watch out for
- Increased defense spending boosts Vehicle Systems and Weapon and Ammunition sales
- Geopolitical instability drives demand for military hardware
- Automotive sector downturn impacts Power Systems revenue
- Supply chain disruptions elevate production costs
- Regulatory scrutiny on arms exports poses risk
Piotroski VR‑10 (Strict, 0-10) 7.0
| Net Income: 840.0m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.01 > 0.02 and ΔFCF/TA -6.43 > 1.0 |
| NWC/Revenue: 10.04% < 20% (prev 17.19%; Δ -7.15% < -1%) |
| CFO/TA 0.06 > 3% & CFO 1.01b > Net Income 840.0m |
| Net Debt (1.87b) to EBITDA (1.96b): 0.96 < 3 |
| Current Ratio: 1.14 > 1.5 & < 3 |
| Outstanding Shares: last quarter (45.9m) vs 12m ago 3.75% < -2% |
| Gross Margin: 44.76% > 18% (prev 0.30%; Δ 4446 % > 0.5%) |
| Asset Turnover: 78.16% > 50% (prev 70.70%; Δ 7.46% > 0%) |
| Interest Coverage Ratio: 11.47 > 6 (EBITDA TTM 1.96b / Interest Expense TTM 129.0m) |
Altman Z'' 2.16
| A: 0.07 (Total Current Assets 9.28b - Total Current Liabilities 8.17b) / Total Assets 15.66b |
| B: 0.20 (Retained Earnings 3.19b / Total Assets 15.66b) |
| C: 0.11 (EBIT TTM 1.48b / Avg Total Assets 14.07b) |
| D: 0.31 (Book Value of Equity 3.28b / Total Liabilities 10.51b) |
| Altman-Z'' Score: 2.16 = BBB |
Beneish M -3.20
| DSRI: 0.94 (Receivables 2.96b/2.52b, Revenue 11.00b/8.83b) |
| GMI: 0.67 (GM 44.76% / 29.98%) |
| AQI: 1.01 (AQ_t 0.25 / AQ_t-1 0.25) |
| SGI: 1.25 (Revenue 11.00b / 8.83b) |
| TATA: -0.01 (NI 840.0m - CFO 1.01b) / TA 15.66b) |
| Beneish M-Score: -3.20 (Cap -4..+1) = AA |
What is the price of RHM shares?
As of March 11, 2026, the stock is trading at EUR 1653.00 with a total of 199,281 shares traded.
Over the past week, the price has changed by +4.62%, over one month by +1.47%, over three months by +2.67% and over the past year by +48.47%.
Over the past week, the price has changed by +4.62%, over one month by +1.47%, over three months by +2.67% and over the past year by +48.47%.
Is RHM a buy, sell or hold?
Rheinmetall has no consensus analysts rating.
What are the forecasts/targets for the RHM price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 2127.3 | 28.7% |
| Analysts Target Price | - | - |
RHM Fundamental Data Overview March 11, 2026
Market Cap USD = 85.61b (74.36b EUR * 1.1513 EUR.USD)
P/E Trailing = 86.4822
P/E Forward = 41.841
P/S = 6.7612
P/B = 15.5976
P/EG = 0.9649
Revenue TTM = 11.00b EUR
EBIT TTM = 1.48b EUR
EBITDA TTM = 1.96b EUR
Long Term Debt = 1.20b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.23b EUR (from shortTermDebt, last quarter)
Debt = 2.43b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.87b EUR (from netDebt column, last quarter)
Enterprise Value = 76.23b EUR (74.36b + Debt 2.43b - CCE 557.0m)
Interest Coverage Ratio = 11.47 (Ebit TTM 1.48b / Interest Expense TTM 129.0m)
EV/FCF = 777.9x (Enterprise Value 76.23b / FCF TTM 98.0m)
FCF Yield = 0.13% (FCF TTM 98.0m / Enterprise Value 76.23b)
FCF Margin = 0.89% (FCF TTM 98.0m / Revenue TTM 11.00b)
Net Margin = 7.64% (Net Income TTM 840.0m / Revenue TTM 11.00b)
Gross Margin = 44.76% ((Revenue TTM 11.00b - Cost of Revenue TTM 6.08b) / Revenue TTM)
Gross Margin QoQ = 21.65% (prev 53.42%)
Tobins Q-Ratio = 4.87 (Enterprise Value 76.23b / Total Assets 15.66b)
Interest Expense / Debt = 1.11% (Interest Expense 27.0m / Debt 2.43b)
Taxrate = 30.0% (87.0m / 290.0m)
NOPAT = 1.04b (EBIT 1.48b * (1 - 30.00%))
Current Ratio = 1.14 (Total Current Assets 9.28b / Total Current Liabilities 8.17b)
Debt / Equity = 0.52 (Debt 2.43b / totalStockholderEquity, last quarter 4.67b)
Debt / EBITDA = 0.96 (Net Debt 1.87b / EBITDA 1.96b)
Debt / FCF = 19.11 (Net Debt 1.87b / FCF TTM 98.0m)
Total Stockholder Equity = 4.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.97% (Net Income 840.0m / Total Assets 15.66b)
RoE = 19.04% (Net Income TTM 840.0m / Total Stockholder Equity 4.41b)
RoCE = 26.36% (EBIT 1.48b / Capital Employed (Equity 4.41b + L.T.Debt 1.20b))
RoIC = 20.98% (NOPAT 1.04b / Invested Capital 4.94b)
WACC = 6.17% (E(74.36b)/V(76.79b) * Re(6.35%) + D(2.43b)/V(76.79b) * Rd(1.11%) * (1-Tc(0.30)))
Discount Rate = 6.35% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.45%
[DCF] Terminal Value 85.72% ; FCFF base≈411.2m ; Y1≈432.3m ; Y5≈506.0m
[DCF] Fair Price = 259.6 (EV 13.75b - Net Debt 1.87b = Equity 11.88b / Shares 45.8m; r=6.17% [WACC]; 5y FCF grow 5.59% → 2.90% )
EPS Correlation: 27.89 | EPS CAGR: -8.53% | SUE: -1.21 | # QB: 0
Revenue Correlation: 73.81 | Revenue CAGR: 12.01% | SUE: -0.27 | # QB: 0
EPS next Year (2026-12-31): EPS=39.38 | Chg7d=+0.020 | Chg30d=-1.467 | Revisions Net=-4 | Growth EPS=+44.7% | Growth Revenue=+36.9%
P/E Trailing = 86.4822
P/E Forward = 41.841
P/S = 6.7612
P/B = 15.5976
P/EG = 0.9649
Revenue TTM = 11.00b EUR
EBIT TTM = 1.48b EUR
EBITDA TTM = 1.96b EUR
Long Term Debt = 1.20b EUR (from longTermDebt, last quarter)
Short Term Debt = 1.23b EUR (from shortTermDebt, last quarter)
Debt = 2.43b EUR (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.87b EUR (from netDebt column, last quarter)
Enterprise Value = 76.23b EUR (74.36b + Debt 2.43b - CCE 557.0m)
Interest Coverage Ratio = 11.47 (Ebit TTM 1.48b / Interest Expense TTM 129.0m)
EV/FCF = 777.9x (Enterprise Value 76.23b / FCF TTM 98.0m)
FCF Yield = 0.13% (FCF TTM 98.0m / Enterprise Value 76.23b)
FCF Margin = 0.89% (FCF TTM 98.0m / Revenue TTM 11.00b)
Net Margin = 7.64% (Net Income TTM 840.0m / Revenue TTM 11.00b)
Gross Margin = 44.76% ((Revenue TTM 11.00b - Cost of Revenue TTM 6.08b) / Revenue TTM)
Gross Margin QoQ = 21.65% (prev 53.42%)
Tobins Q-Ratio = 4.87 (Enterprise Value 76.23b / Total Assets 15.66b)
Interest Expense / Debt = 1.11% (Interest Expense 27.0m / Debt 2.43b)
Taxrate = 30.0% (87.0m / 290.0m)
NOPAT = 1.04b (EBIT 1.48b * (1 - 30.00%))
Current Ratio = 1.14 (Total Current Assets 9.28b / Total Current Liabilities 8.17b)
Debt / Equity = 0.52 (Debt 2.43b / totalStockholderEquity, last quarter 4.67b)
Debt / EBITDA = 0.96 (Net Debt 1.87b / EBITDA 1.96b)
Debt / FCF = 19.11 (Net Debt 1.87b / FCF TTM 98.0m)
Total Stockholder Equity = 4.41b (last 4 quarters mean from totalStockholderEquity)
RoA = 5.97% (Net Income 840.0m / Total Assets 15.66b)
RoE = 19.04% (Net Income TTM 840.0m / Total Stockholder Equity 4.41b)
RoCE = 26.36% (EBIT 1.48b / Capital Employed (Equity 4.41b + L.T.Debt 1.20b))
RoIC = 20.98% (NOPAT 1.04b / Invested Capital 4.94b)
WACC = 6.17% (E(74.36b)/V(76.79b) * Re(6.35%) + D(2.43b)/V(76.79b) * Rd(1.11%) * (1-Tc(0.30)))
Discount Rate = 6.35% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 7.95%
Shares Correlation 3-Years: -33.33 | Cagr: -0.45%
[DCF] Terminal Value 85.72% ; FCFF base≈411.2m ; Y1≈432.3m ; Y5≈506.0m
[DCF] Fair Price = 259.6 (EV 13.75b - Net Debt 1.87b = Equity 11.88b / Shares 45.8m; r=6.17% [WACC]; 5y FCF grow 5.59% → 2.90% )
EPS Correlation: 27.89 | EPS CAGR: -8.53% | SUE: -1.21 | # QB: 0
Revenue Correlation: 73.81 | Revenue CAGR: 12.01% | SUE: -0.27 | # QB: 0
EPS next Year (2026-12-31): EPS=39.38 | Chg7d=+0.020 | Chg30d=-1.467 | Revisions Net=-4 | Growth EPS=+44.7% | Growth Revenue=+36.9%